Cleared Traditional

K221383 - MedtFine Blood Lancet (FDA 510(k) Clearance)

Class II General & Plastic Surgery device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K221383 · Shanghai Carelife International Trading Co. , Ltd. · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2022
Decision
131d
Days
Class 2
Risk

K221383 is an FDA 510(k) clearance for the MedtFine Blood Lancet. Classified as Single Use Only Blood Lancet Without An Integral Sharps Injury Prevention Feature (product code QRK), Class II - Special Controls.

Submitted by Shanghai Carelife International Trading Co. , Ltd. (Shanghai, CN). The FDA issued a Cleared decision on September 21, 2022 after a review of 131 days - within the typical 510(k) review window.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4850 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.

View all Shanghai Carelife International Trading Co. , Ltd. devices

Submission Details

510(k) Number K221383 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 13, 2022
Decision Date September 21, 2022
Days to Decision 131 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
17d slower than avg
Panel avg: 114d · This submission: 131d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code QRK Single Use Only Blood Lancet Without An Integral Sharps Injury Prevention Feature
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4850
Definition A Disposable Blood Lancet Intended For A Single Use That Is Comprised Of A Single Use Blade Attached To A Solid, Nonreusable Base That Is Used To Puncture The Skin To Obtain A Drop Of Blood For Diagnostic Purposes.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Consultant

Shanghai Mind-Link Consulting Co., Ltd.
Evan Hu

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - QRK Single Use Only Blood Lancet Without An Integral Sharps Injury Prevention Feature

All 14
Devices cleared under the same product code (QRK) and FDA review panel - the closest regulatory comparables to K221383.
droplet® personal lancets
K250016 · Htl-Strefa S.A · Jul 2025
Disposable Blood Lancet (Soft Pro)
K244031 · SteriLance Medical (Suzhou), Inc. · Feb 2025
Sterile Lancets for Single Use
K242622 · Ningbo Caremed Medical Products Co., Ltd. · Oct 2024
MICROLET®NEXT Lancet
K241810 · Ascensia Diabetes Care U.S., Inc. · Aug 2024
Lancing System
K232330 · Ningbo Medsun Medical Co., Ltd. · Jan 2024
SG Lanset I, SG Lancets, Soft Lancets
K230712 · Sewon Medical Co. · Dec 2023